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Abstract
Fibrillin-1 is a ubiquitous extracellular matrix molecule that sequesters latent growth factor complexes. A role for fibrillin-1 in
specifying tissue microenvironments has not been elucidated, even though the concept that fibrillin-1 provides extracellular
control of growth factor signaling is currently appreciated. Mutations in FBN1 are mainly responsible for the Marfan
syndrome (MFS), recognized by its pleiotropic clinical features including tall stature and arachnodactyly, aortic dilatation
and dissection, and ectopia lentis. Each of the many different mutations in FBN1 known to cause MFS must lead to similar
clinical features through common mechanisms, proceeding principally through the activation of TGFb signaling. Here we
show that a novel FBN1 mutation in a family with Weill-Marchesani syndrome (WMS) causes thick skin, short stature, and
brachydactyly when replicated in mice. WMS mice confirm that this mutation does not cause MFS. The mutation deletes
three domains in fibrillin-1, abolishing a binding site utilized by ADAMTSLIKE-2, -3, -6, and papilin. Our results place these
ADAMTSLIKE proteins in a molecular pathway involving fibrillin-1 and ADAMTS-10. Investigations of microfibril
ultrastructure in WMS humans and mice demonstrate that modulation of the fibrillin microfibril scaffold can influence
local tissue microenvironments and link fibrillin-1 function to skin homeostasis and the regulation of dermal collagen
production. Hence, pathogenetic mechanisms caused by dysregulated WMS microenvironments diverge from Marfan
pathogenetic mechanisms, which lead to broad activation of TGFb signaling in multiple tissues. We conclude that local
tissue-specific microenvironments, affected in WMS, are maintained by a fibrillin-1 microfibril scaffold, modulated by
ADAMTSLIKE proteins in concert with ADAMTS enzymes.
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Introduction
Mutations in fibrillin-1 cause the pleiotropic features of the
Marfan syndrome (MFS, OMIM#154700). MFS is recognized by
its unique combination of skeletal, cardiovascular, and ocular
features (long bone overgrowth, aortic root dilatation and
dissection, and ectopia lentis). More than a thousand different
mutations in FBN1, the gene for fibrillin-1, are known to cause
MFS, suggesting that the same general pathogenetic mechanisms
are initiated by each of these distinct mutations. In contrast, Weill-
Marchesani syndrome (WMS, OMIM #608328) is a rare disorder
described as ‘‘opposite’’ to MFS [1]. WMS, one of several types of
acromelic chondrodysplasias, is characterized by short stature,
brachydactyly, thick skin, and ectopia lentis. Previous studies
reported that the autosomal dominant form of WMS is caused by
mutations in FBN1 [2,3], while mutations in ADAMTS10 were
shown to cause recessive WMS [4,5]. Since the clinical features of
WMS and MFS may sometimes overlap [6], it is not certain how
rare mutations in FBN1 can bring about WMS instead of MFS.
Additional investigations are required in order to clearly establish
the role of fibrillin-1 in causing WMS.
A role for fibrillin-1 in skin fibrosis was first suggested when a
mutation in Fbn1 was identified in the tight-skin (tsk) mouse [7].
More recently, mutations in FBN1 were found in Stiff Skin
Syndrome (SSKS, OMIM #184900), a rare disorder character-
ized by hard, thick skin and joint contractures [8]. Both the tsk and
SSKS phenotypes are caused by heterozygous mutations.
However, the tsk mutation is a large in-frame gene duplication,
while SSKS mutations are missense mutations confined to exon
37. The molecular mechanisms by which fibrillin-1 regulates skin
fibrosis are obscure. Why the tsk and SSKS mutations do not
cause MFS is also obscure.
Fibrillin-containing microfibrils are small diameter fibrils that
are usually found in bundles or in association with elastic fibers.
Individual fibrillin microfibrils are long and can be extended in
vivo when tissues are under tension [9]. In humans and mice with
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[10,11]. In contrast, fibrillin microfibrils in human scleroderma
skin were disorganized, when labeled and examined by immu-
noelectron microscopy [12]. The latter observation was extended
by ultrastructural studies of fibrillin microfibrils in SSKS [8]. In
SSKS, fibrillin microfibrils were found in large aggregates within
which individual microfibrils appeared to be short [8]. These
electron microscopic observations suggest that structural abnor-
malities in fibrillin microfibrils may underlie the differences
between MFS and SSKS disease pathologies.
Another possibility is that mutations causing SSKS or WMS
perturb growth factor signaling, since fibrillin-1 targets and
sequesters the large latent Transforming Growth Factor b (TGFb)
complex [13,14] as well as multiple Bone Morphogenetic Proteins
(BMPs) and Growth and Differentiation Factor-5 (GDF-5) [15–
17]. In MFS, abnormal activation of TGFb signaling contributes
to phenotypes in the lung [18] and aorta [19], but TGFb signaling
may not be abnormally activated in the skin. In SSKS or WMS
skin, overproduction of collagen may be predicted to be due to
abnormal activation of TGFb. But, it is unclear why abnormal
activation of TGFb signaling would be limited to the skin in SSKS
or WMS and alternatively to the lung and aorta in MFS. Different
mechanisms may be involved in the activation of TGFb signaling
in these disorders and/or important unknown factors may limit
the effects of mutations in fibrillin-1 to specific tissues.
Here we identify a novel mutation in fibrillin-1 in a family with
WMS. In order to reveal the complex mechanisms by which
fibrillin-1 differentially regulates connective tissues, we replicated
this mutation causing human WMS in the mouse. We show that
this mutation does not cause MFS, since the WMS mouse survives
normally and does not display major features of MFS, even in
homozygosity. Instead, WMS mutant mice develop skin fibrosis
associated with distinctive ultrastructural abnormalities in fibrillin
microfibrils. In addition, WMS mice demonstrate retardation of
long bone growth. Therefore, WMS mice recapitulate cardinal
features of human WMS. To elucidate molecular mechanisms of
WMS, we provide evidence that the WMS mutation abolishes the
binding site in fibrillin-1 for a novel family of proteins, the
ADAMTSLIKE (ADAMTSL) proteins. We also connect
ADAMTSL proteins with ADAMTS-10 and propose that these
proteins form a complex with fibrillin-1. These findings implicate
ADAMTSL proteins, together with ADAMTS-10, in the regula-
tion of fibrillin microfibril structure. Insights gained from these
studies are relevant to MFS and to the expanding genetic diseases
that constitute the Marfan-related disorders. Furthermore, our
results point out the importance of fibrillin-1 in the local regulation
of tissue-specific microenvironments.
Results
Identification of an FBN1 genomic deletion in a family
with WMS
A family with autosomal dominant WMS was previously
described, and linkage analysis identified FBN1 on chromosome
15q21.1 as the disease locus [2]. This family includes affected
individuals in three generations (Figure 1a). Affected individuals
exhibited characteristic features of WMS including microspher-
ophakia, ectopia lentis, glaucoma, brachydactyly, short stature,
and thickening of the skin, as previously documented for
individuals 5016, 4084, and 5010 [2]. We further examined
individuals 5010 (45 years of age), 5011 (15 years of age), and 6013
(10 years of age) and unaffected family members. Early removal of
ocular lenses and short stature were common. Mild brachydactyly
of the toe and some limitation of small joints were found in 6013.
5011 showed brachydactyly, more pronounced limitation of large
and small joints, and thickened skin. 5010 showed severe
limitation of small and large joints with pain and loss of dexterity
and thick forearm skin without striae. In addition, all three
individuals showed increased truncal and axial muscle bulk. No
history or clinical evidence of valvular cardiac or aortic disease was
found in this family.
Southern blotting of genomic DNA and PCR followed by DNA
sequencing revealed a heterozygous 7895 nt genomic deletion in
FBN1 (Figure S1a and Figure 1b) with boundaries in introns 8 and
11. PCR results from unaffected and affected family members
demonstrated that the mutation segregated with the disease
(Figure 1b). Transcripts from the mutant allele lacked exons 9–11
(Figure 1b), predicting in-frame translation of fibrillin-1 molecules
in which the first 8-cysteine domain, the proline-rich region, and
EGF-like domain 4 are missing (Figure 1c). No similar mutations
have been reported in the FBN1 mutation database, where only 23
of 1,013 mutations were deletions or insertions [20]. By using
ribonuclease protection assay, we were able to show that the
wildtype and the mutant FBN1 allele were equally expressed
(Figure S1b). Using a quantitative sandwich ELISA, we found that
wildtype and mutant fibrillin-1 proteins were equally secreted by
affected WMS fibroblasts (Figure 1d). Immunofluorescence of skin
from an affected individual (5011) showed fibrillin fibrils that
appeared normal and not fragmented (Figure 1e), unlike the
fragmented fibrils observed in MFS skin [10].
Replication of the WMS mutation in mouse Fbn1
In contrast to the numerous different mutations in FBN1 known
to cause MFS, there is only one report of an FBN1 mutation in a
family with autosomal dominant WMS [3]. There are also reports
of individuals with WMS that overlap with MFS [6]. In order to
test whether the three-domain deletion in fibrillin-1 found in our
family with WMS causes WMS and not MFS, we replicated the
mutation in a mouse model (WMD) using a gene targeting strategy
(Figure 2a). WMD heterozygous (WMD/+) and homozygous
(WMD/WMD) mice breed well and are viable. Both heterozygous
and homozygous mutant mice live longer than 1.5 years with no
signs of aortic disease typical of MFS. Aortic root morphology in
heterozygous and homozygous mutants is normal, even at 10
months of age (Figure 2b and Figure S2), in contrast to
heterozygous and homozygous mutant mouse models of MFS
[11,19,21–23]. In addition, with the exception of the mutant
mgR/mgR [21], which is hypomorphic for normal Fbn1 and dies
during early adulthood, homozygous mutant mouse models of
MFS die in the early postnatal period [11,22,23]. By these two
major criteria for MFS in mice—aortic disease and early death of
homozygotes—WMD mice do not model MFS.
Author Summary
The microenvironment is specified by cell-surface mole-
cules, growth factors, and the extracellular matrix. Here we
report genetic evidence that implicates fibrillin-1, a
ubiquitous extracellular matrix molecule that sequesters
latent growth factor complexes, as a key determinant in
the local control of musculoskeletal and skin microenvi-
ronments. A novel mutation in fibrillin-1 demonstrates that
modulation of the fibrillin microfibril scaffold can influence
tissue microenvironments and result in the clinical features
of Weill-Marchesani syndrome (WMS), including thick skin,
short stature, and brachydactyly. Dysregulated WMS
microenvironments diverge from Marfan pathogenetic
mechanisms, which lead to broad activation of TGFb
signaling in multiple tissues.
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PLoS Genetics | www.plosgenetics.org 2 January 2012 | Volume 8 | Issue 1 | e1002425Figure 1. Characterization of a novel genomic deletion in FBN1 in a family with WMS. (a) Partial pedigree of the family. Affected individuals
are shown as filled symbols. (b) PCR from genomic DNA of selected family members, using primers flanking the deleted region. Only the affected
individuals give rise to the shortened product (1.1 kb), which after DNA sequencing revealed a 7895 nt deletion with boundaries in FBN1 introns 8
(IVS8-1207) and 11 (IVS11+1257). The wildtype product (9.0 kb) was too large to be amplified under the conditions used. (c) Schematic drawing of
Microenvironmental Regulation by Fibrillin-1
PLoS Genetics | www.plosgenetics.org 3 January 2012 | Volume 8 | Issue 1 | e1002425Brachydactyly and short stature are features of WMS, while
arachnodactyly and tall stature are characteristic of MFS.
Therefore, long bones in the WMD mutant mice were measured.
Growth of long bones appeared to be normal in the first two weeks
of postnatal life but was reduced by 3–4 weeks of age in
homozygous mice (WMD/WMD). Measurements of the long
bones at 1 month of age in the WMD/WMD mice using mCT
showed a statistically significant (P,0.05) reduction in lengths of
the radius, ulna, and tibia of 6–10% (Figure 2c) compared to age
and gender matched wildtype controls. At 3–4 weeks of age, length
measurements of metacarpals and proximal and distal phalanges
in fore- and hindpaws were also reduced between 2–23% in the
WMD/+ and WMD/WMD mice (Figure 2d). These findings are
consistent with the WMS phenotype. However, by 5 months of
age, these differences in length were normalized.
Skin fibrosis in WMD mutant mice
Gross examination suggested a thickened, less elastic skin in
WMD mutant mice (Figure 3a). Histology of skin biopsies from
WMD mice showed excessive collagen deposition in the dermis
starting at 1 month of age. Hematoxylin and eosin or Masson’s
Trichrome stains (Figure 3b, 3c) revealed a widened dermal layer
with decreased hypodermal fat, and thicker, more densely packed
collagen fibers in mutants compared to wildtype mice. qPCR
analyses demonstrated upregulated expression of collagen genes in
the skin from mutant mice (Figure 3d). Skin thickness, as
determined by histological stains and detected by touch by 7
months of age, persisted through old age in the mutant mice.
Electron microscopy after immunogold labeling with anti-
fibrillin-1 antibodies showed alterations in fibrillin microfibril
ultrastructure in WMD/+ and WMD/WMD skin: large bundles of
microfibrils as well as microfibrils around elastin cores showed
reduced periodicity of immunogold labeling in the mutants
(Figure 4a,4b). In addition, large accumulations of microfibrils
were prominent in WMD/+ and WMD/WMD skin (Figure 4a),
and elastic fibers appeared moth-eaten compared with wildtype
littermates (Figure 4b). The disorganized appearance of microfi-
brils is better visualized in the three-dimensional aligned tilt series
of immunolabeled microfibrils from WMD/WMD and wildtype
skin samples supplied Videos S1 and S2.
While some areas of the skin appeared normal, electron
microscopic examination of skin from an 18 year old individual
with WMS (unrelated to the WMS family described above)
revealed unusually large abnormal aggregates of microfibrils
(visible at low magnification in Figure 4c, left panel, arrows).
Elastic fibers also appeared moth-eaten (data not shown). Similar
to observations of WMD mutant mouse skin (Figure 4a),
immunogold labeling with antibodies specific for fibrillin-1
demonstrated both irregular labeling of the microfibril aggregates
and periodic labeling of apparently normal microfibrils (Figure 4c,
middle panel). Based on these immunolocalization results with
antibodies specific for fibrillin-1, we conclude that the small and
large aggregates are composed of abnormal bundles of fibrillin-1
microfibrils. Large microfibril aggregates similar to those in
human WMS (Figure 4c, left and middle panels) were found in
skin from older (11–20 month old) WMD/WMD mice (Figure 4c,
right panel). These results provide evidence for a common
pathogenetic mechanism for fibrosis in human WMS and in this
mouse model of WMS.
Uncovering a new molecular pathway for WMS
We previously showed that ADAMTSL-6 interacts with the N-
terminal half of fibrillin-1 with high affinity (KD=80 nM) [24]. In
order to test whether other ADAMTSL family members also bind
to fibrillin-1 and whether the binding site utilized by ADAMTSL-
6 is perturbed by the WMS three-domain deletion in fibrillin-1, we
generated recombinant fibrillin-1 polypeptides, rF84 and
rF84WMD (Figure S3) and rF90 and rF90WMD (Figure 1c), as
well as recombinant human ADAMTSL-1, -2, -3, and mouse
papilin polypeptides (Figure S3). Surface plasmon resonance (SPR)
technology was employed to measure interactions between
fibrillin-1 and ADAMTSL polypeptides. Similar to ADAMTSL-
6 [24], ADAMTSL-2, -3, and papilin polypeptides interacted with
the N-terminal half of fibrillin-1, while ADAMTSL-1 did not.
Binding to the C-terminal half of fibrillin-1 was negative for all
ADAMTSL proteins tested (data not shown). SPR sensorgrams
are shown for ADAMTSL-2 binding to fibrillin-1 and for
ADAMTSL-3 binding to fibrillin-1 (Figure 5a). ADAMTSL-2,
-3, and -6 and papilin polypeptides did not bind to recombinant
fibrillin-1 polypeptides with the WMS three-domain deletion
(Figure 5a and Table S1). Binding constants for all of these
interactions were calculated from the SPR data (Table S1). We
conclude that the fibrillin-1 domains consisting of the first
8-cysteine domain, the proline-rich region, and the 4
th generic
EGF-like domain contain the ADAMTSL binding site(s).
Because recessive WMS is caused by mutations in ADAMTS10
[4,5], FBN1 and ADAMTS10 share a genetic pathway. Therefore,
we hypothesized that fibrillin-1, ADAMTS-10, and some
ADAMTSL proteins form protein complexes. In a pull-down
assay with Ni-NTA as a resin, we showed that full-length, His6-
tagged ADAMTS-10 in media of stably transfected EBNA 293
cells bound to the N-terminal half of fibrillin-1 (Figure 5b). From
SPR interaction studies, a KD of 450 nM was calculated for the
binding of the N-terminal fibrillin-1 polypeptide to the C-terminal
end of ADAMTS-10 (data not shown). The C-terminal recombi-
nant ADAMTS-10 polypeptide used in the SPR studies represents
the noncatalytic region of ADAMTS-10, a region composed
primarily of Tsp1 repeats (Figure S3). SPR also showed that the
domains contained in the recombinant N-terminal half of wildtype (rF90) and WMS deleted fibrillin-1 protein (rF90WMD). The mutation results in the
deletion of exons 9–11, encoding the first 8-cysteine domain, the adjacent proline rich region, and a generic EGF-like domain. Purity of preparations
of rF90 and rF90WMD is shown in Figure S3. Epitopes of monoclonal antibodies used in this study are shown above the full-length molecule. In
addition, the single RGD site and the binding site for LTBP are marked. (d) Sandwich ELISA used to quantitate secretion of wildtype and mutant
fibrillin-1 in culture medium from normal dermal fibroblasts and WMS fibroblasts. Capture antibodies were biotinylated (b), and detector antibodies
were coupled to alkaline phosphatase (ap). The capture and detector antibody pair that recognizes epitopes outside of the deleted region (b201 and
ap78) detected both normal and WMS mutant fibrillin molecules and showed equal levels of fibrillin-1 secretion in both wildtype and WMS fibroblast
medium. When mAb15 was used as a capture antibody, only wildtype fibrillin-1 was detected, because the proline-rich region, which contains the
epitope recognized by mAb15 [33] is deleted in WMS fibrillin-1. Quantitation of fibrillin-1 secretion using the b15ap201 and b15ap78 antibody pairs
showed approximately half the amount of fibrillin-1 in WMS fibroblast medium compared to medium from normal fibroblasts. These results indicate
that equal amounts of normal and mutated fibrillin-1 are secreted by WMS fibroblasts. The differences in total fibrillin-1 amounts measured using the
different pairs are due to differences in affinities of the pairs for the protein standard (rF11). For this experiment, n=3 and the error bars represent the
standard deviation. (e) Immunofluorescence of WMS skin showed a normal fibrillin pattern when mAb201, mAb69, or mab26 were used. Unlike
immunofluorescence of Marfan skin [10], fibrillin-1 staining patterns were not fragmented in WMS skin. Scale bar=20 mm.
doi:10.1371/journal.pgen.1002425.g001
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end of ADAMTSL-3 with high binding affinity (KD=2 nM)
(Figure 5c). However, neither ADAMTSL-2 nor -1 bound to
ADAMTS-10, indicating that ADAMTS enzymes may partner
only with specific ADAMTSL proteins. Taken all together, these
results suggest that direct interactions between fibrillin-1,
ADAMTS-10, and specific ADAMTSL proteins are involved in
the pathogenesis of WMS.
Figure 2. Replication of the WMS mutation in mice. (a) The targeted Fbn1 locus. A neomycin selection cassette (PGK-Neo, flanked by FRT sites)
was placed in the intron between exons 10 and 11. In addition, loxP sites were introduced before exons 10 and 11 and after exon 12. The neomycin
cassette was removed by breeding targeted mice to FLPe mice. Cre-mediated recombination of the loxP sites resulted in deletion of exons 10–12,
replicating the human WMS mutation. (b) Aortic root morphology. In contrast to Marfan mice, the aortic roots of 10 month old mutant mice showed
no signs of fragmentation of the elastic lamellae. Scale bar=25 mm. (c) Length measurements of long bones. mCT measurements revealed a reduction
of 6–10% at 1 month of age, when homozygous mice were compared to gender-matched wildtype littermates (each bar represents the mean and
standard deviation of measurements from 4 animals, n=4). Significant p-values were obtained for all bones when comparisons were between
homozygous and wildtype littermates. (d) Length measurements of skeletal elements in forepaws and hindpaws showed reduced digit length of
metacarpals and proximal phalanges in WMD mutant mice relative to wildtype mice. All analyzed animals were gender matched littermates at 1
month of age (n=5 for each genotype).
doi:10.1371/journal.pgen.1002425.g002
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Based on in vitro studies, we hypothesized that the mutant
WMS fibrillin-1 cannot interact properly in vivo with certain
members of the ADAMTSL family of proteins. To test if
localization of ADAMTSL proteins is altered in WMD mutant
mice, we stained skin with antibodies specific for ADAMTSL-6
[24]. Results showed a reduction in ADAMTSL-6 immunofluo-
rescence in skin from WMD/+ and WMD/WMD mutant mice
compared to wildtype littermate skin (Figure 6a). Fibrillin-1
immunofluorescence was equal in pattern and abundance in
WMD mutant and wildtype mice (data not shown). Since
antibodies specific for ADAMTSL-2 and -3 are not yet available,
we were unable to determine whether these proteins also
colocalize with fibrillin-1 in skin and whether these are also
reduced in WMD mutant mice.
ADAMTSL-6 and ADAMTS-10 promote fibrillin-1 fibril
formation [24,25]. Therefore, we examined human and mouse
fibroblasts for defects in fibrillin-1 fibril formation. The Marfan
cell culture assay [10] was used. In this assay, control fibroblasts
assemble a matrix containing abundant immunofluorescent
Figure 3. Thick skin phenotype in WMD mice. (a) Gross inspection. 7.5 month WMD mice could be identified by touch. Skin felt thicker and was
less elastic in both heterozygous (WMD/+) and homozygous (WMD/WMD) mice compared to wildtype (Fbn1
+/+) littermates. Here, mice were
sacrificed, shaved, and immediately suspended by forceps positioned at the same relative spot between the ears. The ruler is included to show
equivalent magnifications in the photographs. (b) Hematoxylin and eosin staining of skin from 10 month old WMD littermates. Dermal fibers in the
mutant skin appeared to be thicker and more densely packed when compared to the wildtype littermate skin. Scale bar=50 mm. (c) Masson’s
trichrome staining of skin from the same 10 month old littermates as in (b). WMD heterozygous and homozygous mutant skin showed increased
collagen deposition. In addition, in both (b) and (c), the dermis appeared to be wider with a strikingly diminished hypodermal fat layer. Scale
bar=50 mm. (d) qPCR of collagen genes. RNAs were extracted from skin from WMD wildtype and mutant littermates (n=5 for each genotype), and
collagen genes were quantitated by qPCR. Type I and Type III collagen gene expression was found to be significantly upregulated in the
homozygotes.
doi:10.1371/journal.pgen.1002425.g003
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fibrils [10]. Unlike MFS fibroblasts, fibroblasts from a member
(5010) of the WMS family described here showed abundant
immunofluorescent fibrillin-1 fibrils (Figure 6b). However, these
fibrils appeared to be much thinner and less bundled than
control (CRL2418) fibrillin-1 fibrils. Fibroblasts from wildtype,
heterozygous and homozygous WMD littermates also showed
abundant immunofluorescent fibrillin-1 fibrils (Figure 6c). Immu-
nofluorescence staining of WMD/+ and WMD/WMD cultures
suggested thicker bundles of fibrillin-1 fibrils than those in wildtype
cultures (Figure 6c). These results underscore the conclusion that
the WMS mutation in fibrillin-1 works mechanistically differently
Figure 4. Ultrastructural abnormalities in microfibrils in WMD mouse and WMS human skin. (a,b) Immunogold labeling of 9 month old
wildtype and WMD mutant skin. Wildtype microfibrils decorated with fibrillin-1 antibodies showed periodic gold labeling along the lengths of
individual microfibrils in the absence of elastin (Fbn1
+/+, a) and on the periphery of amorphous, darkly stained elastin cores (Fbn1
+/+, b). In contrast,
fibrillin microfibrils in WMD mutant skin showed reduced immunogold periodicity along microfibrils and larger and denser accumulations of
microfibril aggregates (WMD/+ and WMD/WMD, a); elastic fibers appeared to be moth-eaten and also showed reduced fibrillin-1 periodic labeling (b).
Scale bar=300 nm for all panels in a,b. (c) Extreme ultrastructural appearance of abnormal microfibril aggregates in both human WMS and mouse
WMD skin. Large dense aggregates of microfibrils were easily identified at low magnification in the skin of an 18 year old individual with WMS (left
panel, arrows). Immunogold labeling demonstrated both normal periodic microfibrils (black arrowheads) and irregularly labeled microfibrils (white
arrowheads) (middle panel). Large dense aggregates of microfibrils were also found in older WMD mutant mouse skin. One such aggregate is shown
in skin from a 17 month old homozygous (WMD/WMD) mouse. Scale bars=500 nm.
doi:10.1371/journal.pgen.1002425.g004
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suggest that the mutant WMS fibrillin-1 causes defects in fibrillin-1
fibril aggregation or bundling, but observed differences between
the human WMS and the mouse WMD cultures cannot currently
be explained.
Another potential mechanism contributing to pathogenesis of
WMS is abnormal activation of TGFb signaling. Our findings of
upregulated collagen genes in the skin of WMD mice and
increased Trichrome staining of WMD dermis (Figure 3) suggested
increased TGFb signaling. However, Western blotting for pSmad
Figure 5. Biochemical analyses of interactions among ADAMTSL proteins, fibrillin-1, and ADAMTS-10. (a) SPR sensorgrams showing
binding of different concentrations of soluble ligands to the N-terminal half of fibrillin-1 (rF90), coupled onto a chip. Full-length ADAMTSL-2 (320-
0 nM) interacts with rF90, as does the C-terminal end of ADAMTSL-3 (80-0 nM). No binding was detected when rF90WMD was used, demonstrating
that the binding site for ADAMTSL proteins resides in the deleted region. (b) Fibrillin-1/ADAMTS-10 pull-down assay. Conditioned medium from
transfected cells expressing full-length ADAMTS-10 with a C-terminal His6-tag was incubated with increasing amounts of rF11 (N-terminal half of
fibrillin-1, similar to rF90 but lacking the His6-tag). ADAMTS-10 complexes were pulled down after incubation with Nickel NTA resin. SDS-PAGE
followed by immunoblotting (IB) with anti-fibrillin-1 antibody (9543) showed the presence of fibrillin-1 in the pulled-down ADAMTS-10 complexes.
Conditioned medium from untransfected cells (2) was subjected to the same procedure and served as a control. Even though rF11 was added in
similar amounts to the control medium, no fibrillin-1 was pulled-down, demonstrating the specificity of the interaction between ADAMTS-10 and
fibrillin-1. (c) SPR sensorgrams showing binding of different concentrations (80-0 nM) of soluble C-terminal ADAMTSL-3 to the C-terminal end of
ADAMTS-10, coupled to a chip. Calculated KD for this interaction was 2 nM.
doi:10.1371/journal.pgen.1002425.g005
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multiple time points (data not shown), and qPCR quantitation of
TGFb-responsive genes such as Ctgf, Pai1, and Postn also
demonstrated no differences at multiple time points (data not
shown). When total (Figure 7a) and active TGFb (Figure 7b) were
measured in the medium of human cultured fibroblasts, no
significant difference was found between control and WMS
fibroblasts. Skin samples from heterozygous and homozygous
WMD mice of different ages were examined for the presence of
myofibroblasts. Staining with antibodies specific for a-smooth
muscle actin did not reveal increased numbers of myofibroblasts in
mutant WMD mice (Figure 7c).
We also tested interactions between Latent TGFb Binding
Proteins (LTBPs) and ADAMTSL proteins, since an interaction
between ADAMTSL-2 and the middle region of LTBP-1 was
previously identified [26]. SPR binding studies (summarized in
Table S2) showed no interaction between ADAMTSL-2 and the
middle region of LTBP-1 (rL1-M [13]). However, binding
between ADAMTSL-2 and the C-terminal domains of LTBP-1
present in rL1-K [13] was detected. Binding between ADAMTSL-
3 and the C-terminal domains of LTBP-1 was also detected, but
neither ADAMTSL-2 nor -3 interacted with LTBP-4.
Discussion
WMS is considered to be clinically homogenous, even though
the genetic basis of WMS is heterogeneous [27]. Both recessive
and dominant forms of WMS present equally with myopia,
glaucoma, cataract, short stature, brachydactyly, thick skin, and
muscular build. There may be significant differences in incidence
Figure 6. Immunofluorescence analyses of WMS skin and fibroblast cultures. (a) Immunolocalization of ADAMTSL-6 on P16 wildtype,
heterozygous and homozygous WMD littermates. Antibodies specific for ADAMTSL-6 [24] were used to stain littermate skin. As previously shown [24],
ADAMTSL-6 staining was similar to fibrillin-1 immunostaining in wildtype skin. WMD mutant skin showed a reduction in ADAMTSL-6 immunostaining,
indicating that deletion of the ADAMTSL binding site in fibrillin-1 prevents ADAMTSL-6 from binding to fibrillin-1 in vivo. (b) Human fibroblast cell
cultures stained with antibodies to fibrillin-1 (pAb9543) after 4 days and 10 days of culture. Control (CRL2418) fibroblasts elaborated a typical fibrillin-
1 fibril matrix that was clearly abundant at day 4 and day 10. In contrast, WMS (5010) fibroblasts deposited abundant fibrillin-1 fibrils at day 4, but
these fibrils were thinner and more diffuse. Even after 10 days in culture, the WMS fibroblasts failed to establish prominent bundles of fibrillin fibrils.
(c) Fibroblast cultures from wildtype, heterozygous, and homozygous WMD mice stained with anti-fibrillin-1 (pAb9543) after 4 days in culture. Mutant
fibroblast cultures elaborated typical abundant, long fibrillin-1 fibrils that appeared somewhat thicker than fibrils in wildtype cultures. Scale
bars=50 mm.
doi:10.1371/journal.pgen.1002425.g006
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PLoS Genetics | www.plosgenetics.org 9 January 2012 | Volume 8 | Issue 1 | e1002425Figure 7. Measurements of TGF-b in cultured fibroblasts; a-smooth muscle actin staining. (a) WMS fibroblasts (family members 5016 and
5010) secreted equal amounts of total TGF-b protein compared to controls (C1, C2, C3, and C4). (b) No significant differences were detected in
amounts of active TGF-b present in the media of WMS fibroblasts compared to controls. Medium containing 10% fetal bovine serum was used to
show baseline values. For experiments in (a) and (b), n=2 or 3, and the error bars represent the standard deviation. (c) Skin from 6-month old
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the recessive and dominant forms [27], but these features are also
common to both. Currently, there is a single report of a mutation
in FBN1 in a family with dominant WMS [3].
Results presented here identify a novel mutation in FBN1 in a
family with dominant WMS, which was previously linked to FBN1
[2]. The mutation is predicted to result in fibrillin-1 molecules that
lack the first 8-cysteine domain, the proline-rich region, and the
adjacent EGF-like domain. Replication of this mutation in mouse
Fbn1 clearly demonstrated that the mutation reproduces at least
one cardinal feature of WMS—thick skin—and does not cause the
clinical equivalent of MFS. Reduced long bone growth was also
found in WMD mice, consistent with the human WMS traits of
short stature and brachydactyly. However, by 5 months of age,
long bone growth was normalized, perhaps reflecting differences
between humans, in whom growth plate closure occurs at skeletal
maturity, and rodents, whose growth plates fail to close [28], and
who grow for a longer period of time than humans using cellular
processes which are not active in adult humans [29]. In addition,
hypermuscularity, a feature of human WMS, is also found in
WMD mutant mice (data not shown).
Biochemical studies comparing wildtype and WMS mutant
fibrillin-1 revealed that the WMS mutation abolished a specific
binding site in fibrillin-1 for ADAMTSL-2, -3, -6 and papilin.
Further biochemical studies suggested that specific ADAMTSL
proteins may interact with ADAMTS-10 and that ADAMTS-10
binds to fibrillin-1. Our results are consistent with previous studies
of papilin, the first of the ADAMTSL proteins to be described, and
procollagen N-proteinase (now called ADAMTS-2), which
indicated that the ‘‘papilin cassette’’ (homologous to the
noncatalytic regions of ADAMTS enzymes) may interact with
ADAMTS metalloproteinases [30]. In addition, binding between
ADAMTS-10 and fibrillin-1 was recently demonstrated [25].
Therefore, we propose that a ternary complex of ADAMTSL,
ADAMTS-10, and fibrillin-1 may be formed. Such a ternary
complex is depicted in Figure 8, showing how ADAMTSL-3 and
ADAMTS-10 may bind as a complex to fibrillin-1 in microfibrils.
Mutations in ADAMTSL2 cause geleophysic dysplasia [26].
Mutations in ADAMTS17 cause a Weill-Marchesani-like syndrome
[31], and mutations in ADAMTSL4 cause autosomal recessive
isolated ectopia lentis [32]. Both geleophysic dysplasia and WMS
are acromelic dysplasias sharing features of short stature, brachy-
dactyly, thick skin, limited joint mobility, and hypermuscularity.
Ectopia lentis is a common feature of MFS and WMS. All together,
these related genetic disorders suggest that specific ADAMTSL (at
least ADAMTSL-2 and -4) and ADAMTS (ADAMTS-10 and -17)
proteins modulate fibrillin-1 function in the skeleton, skin, joints,
muscle, and eye. Our biochemical data also implicate ADAMTSL-
3 and -6 in these pathways. Whether all members of the
ADAMTSL/ADAMTS family perform similar roles in the
modulation of fibrillin-1 function is unknown. However, if similar
functions are performed, differences in temporal and spatial
regulation of the expression of these genes could account for
tissue-specific variation in these related disorders.
An in-frame deletion of 24 nucleotides was found in FBN1 to
cause autosomal dominant WMS [3]. This mutation
(5074_5097del) deletes 8 amino acid residues (R
1692 –Y
1699) from
the fifth 8-cysteine domain (also called TB5) in fibrillin-1. When
fibrillin-1 is modeled within microfibrils [33], the fifth 8-cysteine
domain in one molecule of fibrillin-1 is close to the ADAMTSL
binding site in an adjacent fibrillin-1 molecule (Figure 8). Recently,
16 novel heterozygous mutations in FBN1 causing geleophysic
dysplasia or acromicric dysplasia were also identified in the fifth 8-
cysteine domain [34]. WMS, geleophysic dysplasia, and acromic-
ric dysplasia are members of the acromelic group of dysplasias
with similar as well as distinctive clinical features. In our model,
the clustering of fibrillin-1 domains associated with acromelic
dysplasias and with binding sites for ADAMTSL proteins involved
in acromelic dysplasias may specify a new microenvironment
controlling thick skin and musculoskeletal growth.
It is interesting that, when fibrillin-1 is modeled within
microfibrils [33], the single RGD-containing domain in fibrillin-
1 is close to the ADAMTSL binding site in fibrillin-1 (Figure 8).
Integrin binding to RGD sites is known to perform important roles
in matrix assembly [35] and to be critically dependent on the
surrounding sequences, which can silence RGD function [36].
SSKS is caused by missense mutations in FBN1 exon 37, which
encodes the domain containing the RGD site [8]. Therefore, it can
be speculated that SSKS mutations in FBN1 lead to diminished
integrin activity. Because dermal fibrosis and the abnormal
ultrastructural appearance of fibrillin microfibrils were similar in
both SSKS [8] and WMS (Figure 4), it seems likely that integrin
interactions with fibrillin-1 are perturbed in both SSKS and
WMS. Furthermore, the proximity of the RGD-containing
domain to the ADAMTSL binding site in fibrillin-1 suggests that
integrins may cooperate with ADAMTSL proteins and
ADAMTS-10 in modulating fibrillin microfibril [24,25] aggrega-
tion and organization. However, the molecular mechanisms of this
cooperation remain unknown.
Abnormal TGFb signaling may play a role in these disorders,
since fibrillin-1 microfibrils target and sequester the large latent
TGFb complex [13]. We found upregulated collagen gene
expression and increased Trichrome staining in the skin of WMD
mutant mice, results that are consistent with activated TGFb
signaling. In addition, molecular interactions of LTBP-1 with both
ADAMTSL-2 and ADAMTSL-3 were determined, suggesting that
loss of the ADAMTSL binding site in WMD mutant mice might
render the large latent TGFb complex more susceptible to
activation. However, if activation of TGFb signaling underlies the
dermal fibrosis in WMD mutant mice, this activation of signaling
did not manifest detectable differences in other conventional TGFb
signaling readouts (e.g., increased a-smooth muscle actin positive
cells). It has been recently speculated that mechanical forces may be
required to activate the latent TGFb complex [37]. Therefore, it is
possible that local changes in the fibrillin microfibril matrix could
influence force-dependent activation of latent TGFb, perhaps
leading to a local increase in signaling.
Activation of TGFb signaling has been shown for geleophysic
dysplasia [26,34], acromicric dysplasia [34], and for MFS [18,19].
We propose that, in consort with the different tissue-specific
manifestations of disease in WMS and MFS, activation of TGFb
signaling in these diseases may be limited (WMS) or more global
(MFS) in scope. In MFS, the broad activation of TGFb signaling
in multiple tissues matches the pleiotropic features of the disease
and the requirement for general pathogenetic mechanisms
initiated by multiple different disease-causing mutations. In the
case of WMS, we propose that fibrosis limited to the skin is due to
the dysregulated interaction between abnormally organized
wildtype and WMD/WMD littermates showed no difference in numbers of cells stained by an a-smooth muscle actin antibody (red). DAPI nuclear
stain is blue. Scale bar=20 mm.
doi:10.1371/journal.pgen.1002425.g007
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microenvironments. Our data suggest that direct interactions
between ADAMTSL proteins, fibrillin-1, and LTBP-1 (Figure 8)
may be dysregulated in WMS, leading to concomitant structural
and signaling abnormalities within local spaces. However, the
discrepancy in the data measuring TGFb activity between our
WMS fibroblast cultures and geleophysic and acromicric dysplasia
fibroblast cultures [26,34] is not yet understood. Although further
investigations are required in order to determine the roles of
ADAMTSL/ADAMTS-10 complexes, integrins, and LTBP-1 in
the fine regulation of TGFb signaling in WMS skin fibrosis, we
conclude that these molecular pathways work locally—in micro-
environments—to control skin fibrosis. While the importance of
the microenvironment is appreciated in development and cancer
[38], this is to our knowledge the first evidence for microenviron-
mental regulation by fibrillin-1.
In summary, our results suggest an improved concept of the
architectural and regulatory functions of fibrillin-1. Previously, the
microfibrils of elastic, distensible tissues were thought to function
mechanically only as a limiting component for a cross-linked,
isotropic elastin matrix. Subsequently, the attachment of LTBPs
and BMPs demonstrated that fibrillin microfibrils participate in
the storage and release of growth factors. Now we show that
fibrillin-1 also selectively binds the metalloproteinase ADAMTS-
10 and some non-enzymatic ADAMTSL proteins, enabling a
clustering of these protein complexes in the vicinity of the fibrillin-
1 RGD site and suggesting the potential for integrin involvement
in ADAMTS/ADAMTSL/fibrillin functions. The established
mutual affinity of the protein components of this cluster opens
varied biochemical pathways that need to be explored in the
future. The genetic evidence in humans and mice shows that
perturbation of such biochemical pathways can lead to significant
pathobiological consequences. In addition, the genetic evidence
clearly demonstrates that fibrillin-1 microfibrils, although ubiqui-
tous structural elements in the connective tissue space, perform
local functions to support tissue microenvironments.
From the perspective of normal development and tissue
homeostasis, we propose that the fibrillin microenvironment may
Figure 8. Model of fibrillin-1 containing microfibrils showing the locations of binding sites for ADAMTSL proteins, LTBP-1, and
integrins. This model of fibrillin-1 molecules arranged as parallel, staggered molecules within the beads-on-a-string microfibril was previously
proposed [33]. Two staggered fibrillin-1 molecules are shown with colored domains (see Figure 1c for domain structure), while other fibrillin
molecules within the microfibril are depicted as dashed black lines. Beaded regions of the microfibril are represented as gray scalloped circles. The
inset shows the N-terminus (black) of one molecule extending through cbEGF5 and crossing over the middle portion of a second molecule (shown
from Hybrid2 through cbEGF27). In this model, binding sites for ADAMTSL proteins (within the first 8-cysteine domain, the proline-rich domain, and
the adjacent generic EGF-like domain) and for LTBP-1 (within the first hybrid domain) on one molecule are very close to the integrin-binding RGD site
(contained in the fourth 8-cysteine domain) on a second molecule. Mutations in the fourth 8-cysteine domain can cause SSKS, presumably by
disrupting integrin binding. The fifth 8-cysteine domain or TB5 contains mutations in FBN1 that result in WMS [3], geleophysic (GD) or acromicric
dysplasia (AD) [34]. Mutations in ADAMTSL2 also lead to GD, and mutations in ADAMTS10 lead to WMS. We propose that this cluster of molecular
interactions (magnified in the inset) constitutes a microenvironment controlling thick skin and musculoskeletal growth.
doi:10.1371/journal.pgen.1002425.g008
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ings. The extended fibrillin fibril may function as a sensor for
mechanical distortion of the matrix, signaling the cell when there is
a need for additional, reinforcing structural components like
collagens. The presence of large latent TGFb complexes within
the fibrillin microenvironment conveniently couples matrix
mechanics with available signals for upregulation of collagens.
Installation of new structural materials into pre-existing matrices
likely requires remodeling enzymes like metalloproteinases.
ADAMTS enzymes, localized to the fibrillin microenvironment
as well, possibly with the help of ADAMTSL proteins, could serve
such purposes, or they might participate in the activation of
nearby latent growth factors. Understanding pathogenetic mech-
anisms underlying WMS and MFS will elucidate the local, fine
adjustments required for growth, homeostasis, and repair.
Materials and Methods
Ethics statement
Clinical studies were performed with informed consent and
local OHSU Internal Review Board approval. All mouse work was
approved by the OHSU IACUC committee.
Individuals with WMS
The family pedigree shown in Figure 1 has been previously
described [2]. Dermal fibroblast cultures were established from
punch biopsies obtained with informed consent and local OHSU
IRB approval. All participants were evaluated for myopia,
glaucoma and dislocated lenses, for musculoskeletal and skin
characteristics, and for cardiac or aortic disease assessed by history
and/or by auscultation. This family has been followed for more
than 15 years with no clinical evidence of valvular cardiac or aortic
disease. A second unrelated individual, designated WMS2, was
seen who had been previously diagnosed with WMS. At 18 years
old, she had a history of early high myopia and presented with
headaches secondary to glaucoma. She had short stature, mild
brachydactyly, microspherophakia, and apparently normal joints
and skin. A punch biopsy was obtained with informed consent.
Mutation detection
Genomic DNA was extracted from cultured WMS 5016 or
normal skin fibroblasts (NSF) or EDTA whole blood using
standard procedures. Individual FBN1 exons were amplified by
PCR of genomic DNA using intronic primers. Overlapping FBN1
cDNAs were amplified by PCR using exonic primers (for
sequences see Table S3). PCR products were sequenced.
Southern blotting
Genomic DNA was digested (using HindIII, Bsu36I, NcoI,
SpeI, SspI), separated electrophoretically and transferred to a
nylon membrane. The membrane was probed with a 727 bp
cDNA fragment of FBN1 encompassing exons 8–12, radiolabeled
with
32P-adCTP in the presence of random and specific primers,
and exposed after stringent washing to film for autoradiography.
Ribonuclease protection assay
Primers flanking FBN1 exons 9, 11, 21, and 37 were used to
generate fragments of genomic NSF DNA, and the products were
cloned into the pGEM-T-Easy vector (Promega). Radiolabeled
probes were hybridized to total RNA of normal or WMS patient
fibroblasts, followed by ribonuclease digestion to degrade unhy-
bridized regions (RPA III kit, Ambion). Protected fragments were
separated by acrylamide gel electrophoresis, and quantitated by
phosphorimager (STORM, Molecular Diagnostics).
Generation of mice
All materials used for the generation of the WMD mouse line
originated from C57BL/6 mice (see Figure 4 for design of
targeting vector). The floxed WMD mouse line was generated by
Ozgene Pty. Ltd. (Bentley, Australia). The neomycin selection
cassette was removed by breeding targeted mice to FLPe mice.
Cre-mediated removal of Fbn1 exons 10–12 in all cells was
accomplished by breeding floxed WMD mice to mice containing
Cre-recombinase knocked into the Rosa26 locus (on a C57Bl/6
background). For this study, heterozygous WMD mice were bred
to yield wildtype, heterozygous, and homozygous littermates for
analyses. Genotyping was by PCR using primer pairs annealing
within and outside of the deleted genomic region (for sequences
see Table S4). All procedures performed on mice were approved
by OHSU IACUC.
Antibodies
Fibrillin-1 polyclonal antibody (pAb 9543) and monoclonal
antibodies (mAb) 15, 78, 201, and 69 have been previously
described [9–12,33]. Polyclonal antibody specific for ADAMTSL-
6 was generated as described [24]. Antibody to a-smooth muscle
actin was purchased from Sigma.
Cell cultures
CRL2418, a normal dermal fibroblast cell line, was purchased
from American Type Culture Collection. WMS fibroblasts were
established from a punch biopsy of skin from family member 5010.
Explant cultures of P4 mouse skin were established from WMD
wildtype, heterozygous and homozygous littermates. 1 ml cham-
ber slides were seeded at a density of 200,000 cells/ml and
incubated in DMEM, including 10% fetal bovine serum, for 3 to
10 days, as indicated in the figures. Media from the 3-day
incubation was collected and stored at 220uC for sandwich
ELISAs. Cell layers were analyzed by immunofluorescence.
Sandwich ELISA
96-well ELISA plates (Corning) were coated with 100 mlo f
5 mg/ml streptavidin (Pierce) and incubated overnight at 4uC.
Excess streptavidin was removed by extensive washing, and
100 ml/well of 0.25 mg/ml biotinylated monoclonal antibodies
(B15 or B201) were incubated at 25uC for 1 hour. After washing,
wells were incubated overnight at 4uC with culture medium
samples (from 3-day chamber slide cultures of WMS or control
fibroblasts). In addition, serially diluted protein standards (rF11)
were applied separately to wells coated with biotinylated
antibodies and incubated overnight at 4uC. Unbound proteins
were removed by washing, and alkaline phosphatase-conjugated
monoclonal antibodies (AP201 0.05 mg/ml or AP78 0.5 mg/ml)
were incubated in the wells for 1 hour at 25uC. Invitrogen’s
ELISA amplification system was used for colorimetric detection,
according to the manufacturer’s protocol. Absorbance was
recorded using a Molecular Devices Emax plate spectrophotom-
eter and was then converted to mg/ml, according to standard
curve values. Calculations to determine concentration were
performed on Excel software.
Immunofluorescence
Skin was obtained by punch biopsy from a son of family
member 5010, following informed consent. Skin was also obtained
from WMD wildtype and mutant mouse littermates in accordance
with OHSU approved IACUC procedures. Immunofluorescence
of skin as well as cultured fibroblasts was performed as previously
described [10,11].
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Histology was performed by the OHSU Histology Core, using
standard procedures for Hematoxylin and Eosin and Masson
Trichrome stains (Sigma, St. Louis, MO).
mCT
For mCT analyses, mice were sacrificed at specified time points.
mCT measurements and analyses were performed with a Scanco
mCT 35 (Scanco Medical, Basserdorf, Switzerland) scanner,
according to the manufacturer’s instructions.
Quantitative real-time PCR (qPCR)
qPCR using RNA from WMD and wildtype control mouse skin
was performed as previously described [11]. Primers for mouse
Col1A1, Col1A2, and Col3A1 were purchased from SABiosciences
(Frederick, MD). The primers for mouse Periostin (Postn; forward:
59-catcttcctcagcctccttg-39; reverse: 59-tcagaagctccctttcttcg-39), Plas-
minogen activator inhibitor-1 (Pai1; forward: 59-ctttacccctccgagaatcc-
39; reverse: 59-gacacgccatagggagagaa-39), and Connective tissue growth
factor (Ctgf; forward: 59-ctgcctaccgactggaagac-39; reverse: 59-
ttggtaactcgggtggagat-39) were individually designed and tested
for amplification efficiency.
Electron microscopy
Immunoelectron microscopy of tissues from WMD mouse
littermates was performed as described [11]. Tissues were labeled
en bloc with anti-fibrillin-1 (pAb 9543) followed by 5 nm
secondary gold conjugated antibodies (Amersham Biosciences).
Aligned tilt series were acquired from 500 nm thick sections as
described [11].
Expression plasmids
Expression vectors carrying full length human LTBP-4S and
LTBP-1S were kindly provided by Dr. Jorma Keski-Oja and Dr.
Daniel Rifkin. The rF90WMD and rF84WMD expression
constructs were cloned from WMS fibroblast cDNA. Full-length
ADAMTSL1 was obtained from human fibroblast cDNA. For
cloning of ADAMTSL2, a mouse full length cDNA clone (ID
RIKEN cDNA F83011122) was obtained. Constructs for
ADAMTSL3 were made using a clone (RIKEN) and mouse lung
cDNA. Constructs for Papilin were cloned from mouse fibroblast
cDNA. A full length human ADAMTS10 clone (SC309981) was
purchased from Origene, and mutations in this clone were
corrected.
Production of recombinant proteins
Generation of recombinant polypeptides representing fragments
of LTBP-1 was previously described [13]. The generation of rF90
was described before [16]. All fibrillin and ADAMTSL expression
constructs were transfected into 293/EBNA cells for protein
expression. All proteins were purified using metal ion affinity
chromatography. Protein domain boundaries for the constructs
are depicted in Figure 1 and Figure S3.
Surface plasmon resonance (SPR)
Binding analyses were performed using a BIAcoreX (BIAcore
AB, Uppsala, Sweden). Recombinant full length ADAMTSL-1, -2,
LTBP-1, -4, and polypeptides ADAMTS-10 C-term, rL1K, rLM,
rLN, rF6, rF90, and rF90WMD were covalently coupled to CM5
sensor chips (research grade) using the amine coupling kit
following the manufacturer’s instructions (BIAcore AB). Binding
assays were performed at 25uC in 10 mM Hepes buffer, pH 7.4,
containing 0.15 M NaCl, 3 mM EDTA, and 0.005% (v/v) P20
surfactant (HBS-EP buffer, BIAcore AB). Kinetic constants were
calculated by nonlinear fitting of association and dissociation
curves (BIAevaluation 3.0 software). Equilibrium dissociation
constants (KD) were then calculated as the ratio of kd/ka.
Pull-down assay
Cell culture media (1 ml) from stably transfected 293/EBNA
cells expressing ADAMTS-10 with a C-terminal His6-tag, and
media from untransfected EBNA cells as a control were adjusted
to 20 mM Tris pH 7.8, 5 mM imidazole and incubated for 1 h
with 5–20 mg of rF11 (N-terminal half of fibrillin-1, without a His6-
tag). Subsequently, 50 ml of a 50% Ni-NTA slurry in water was
added and incubated for 2 hs. The resin was washed and boiled in
50 ml1 6 SDS loading buffer. Eluted proteins were subjected to
SDS-PAGE followed by immunoblotting with polyclonal anti
fibrillin-1 antibody 9543.
ELISA assay for active and total TGF-b1
The quantity of TGF-b1 in 100 ml culture medium from
confluent fibroblasts (200,000 cells/ml grown for 72 h in 1 ml
chamber slides) was determined using the TGF-b1 EMax
Immnunoassay kit (Promega). WMS and control fibroblasts were
utilized.
Statistical analysis
Prism 5.02 for Windows (GraphPad, San Diego, CA) was used
to perform One-way Analysis of Variance (1-way ANOVA)
followed by post-test analysis with Tukey’s multiple comparison
test. p-values,0.05 were considered significant.
Supporting Information
Figure S1 Analysis of genomic WMS DNA and mRNA. (a)
Southern blot of control (C) and WMS (W) genomic DNA probed
with radiolabeled FBN1 cDNA from exons 8–12. In the WMS
DNA, new bands (indicated by arrows) of 6.0 kb (Bsu36I digest)
and 3.8 kb (HindIII digest) are observed, along with an apparent
reduction of intensity in other bands. (b) RNAse protection assay.
Total RNA preparations from control (C) and WMS (W) skin
fibroblasts were hybridized to radiolabeled antisense probes from
FBN1 exons 9 and 11 (internal to the deleted region) and exons 21
and 37 (external). The signal intensity of protected internal- and
external-region in the control sample showed a ratio of close to 1,
indicating that FBN1 mRNAs were detected equivalently regard-
less of the probe location. In the WMS RNA, however, the probes
internal to the deleted region yielded a signal which was reduced
by about 50% relative to probes external to the deletion.
Therefore, WMS RNA contains approximately equal amounts
of normal and deleted mutant FBN1 transcripts.
(TIF)





WMD/WMD) littermates. Hearts were dissected with the
ascending aorta, aortic arch, and a portion of the descending
aorta intact to maintain proper orientation. Aortic roots were
fixed, cross-sectioned, and stained with toluidine blue. No
differences between mutants and wildtype littermates were
observed in aortic root morphology, diameter, or wall thickness.
Scale bar=100 mm.
(TIF)
Figure S3 Domain structures and gels showing additional
recombinant proteins used in these studies. (a) Domains contained
in recombinant papilin and ADAMTSL polypeptides, recombinant
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ed schematically. (b) Coomassie stained gels of new recombinant
proteins demonstrate the purity of the preparations.
(TIF)
Table S1 Dissociation constants (KD) determined using SPR
technology. Titrated concentrations of papilin and ADAMTSL
molecules (analytes) were injected over immobilized fibrillin-1
peptides (ligands on chip). Full-length ADAMTSL-2 and the C-
terminal ADAMTSL-3 polypeptide bind well to wildtype fibrillin-
1 peptides but fail to bind to fibrillin-1 peptides containing the
WMS deletion. Similarly, binding of papilin fragments suggests
interactions with fibrillin-1 that are abolished in a peptide
containing the deleted domains.
(DOC)
Table S2 SPR interaction studies between ADAMTSL and
LTBP peptides. (a) ADAMTSL-2 interacted with wildtype
fibrillin-1 (rF90) but not with mutant rF90 (rF90WMD). However,
the C-terminal end of LTBP-1 (rL1K) interacted with both
wildtype and mutant WMD fibrillin-1 peptides. (b) Full-length
ADAMTSL-2 failed to interact with the recombinant middle
region of LTBP-1 (rL1-M). However, LTBP-1 recombinant C-
terminal rL1K interacted with ADAMTSL-2 and -3. Binding was
observed between ADAMTSL-3 and rL1M.
(DOC)
Table S3 Specific primers used to detect the deletion in FBN1
cDNA and genomic DNA by PCR.
(DOC)
Table S4 Primers used to determine the genotype of WMD
mutant mice. Primers anneal within and outside the deleted
genomic region.
(DOC)
Video S1 Aligned tilt series of immunolabeled fibrillin-1
microfibrils in wildtype skin. Elastic fiber present in wildtype skin
displays periodic labeling of fibrillin microfibrils with pAb 9543.
Periodic immunogold labeling emphasizes the organized appear-
ance of wildtype microfibrils.
(WMV)
Video S2 Aligned tilt series of immunolabeled fibrillin-1
microfibrils in mutant WMD/WMD skin. Elastic fiber present in
homozygous mutant WMD skin shows much reduced periodicity
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